Home Featured

Featured

Market Morning: S&P Says More Spending, Hong Kong Ping Pong, Riots, Food Prices Soar

ME Staff - June 1, 2020

Market Morning: Moderna Miracle? Autos Fly On Lockdown Easing, NY Governor Sued

Market Morning: London Legalizes Moving, Congress and Fed Want More Spending, European Banks Fall

Market Morning: Beef Prices to Record Highs, China Warns of Conflict, Germany Against ECB

Market Morning: Boeing Going On, Unemployment Confusion, Gilead Treatment, China Barely Contracts

Vertex Eyes a Half Billion Dollar Boost with Upcoming sNDA Decision

Jennifer Aldershot - January 15, 2016

Thursday’s Movers and Shakers in Biotech

Jennifer Aldershot - January 14, 2016

Gobal Indices except China Gain Amid Favorable Data

ME Contributor - January 13, 2016

enGene Shines with a Host of Big Name Collaborations

ME Contributor - January 13, 2016

Here’s how to get an Exposure to Moderna’s Private Pipeline

Roger Hannington - January 12, 2016

Ariad is Targeting a Japanese Payday with Iclusig

ME Contributor - January 11, 2016

Is Guardant Next in Line for a Big Pharma Suitor?

Jennifer Aldershot - January 8, 2016

Amgen is Targeting a Blockbuster SOC Upheaval in Multiple Myeloma

ME Staff - January 7, 2016

The Who and What of PD-1 and Janus Kinase Inhibition

ME Contributor - January 6, 2016

An Off The Radar Industry With A Billion Dollar Target

Roger Hannington - January 5, 2016

1...123124125...134 Page 124 of 134

/* */

EDITOR PICKS

Market Morning: S&P Says More Spending, Hong Kong Ping Pong, Riots,...

June 1, 2020

Market Morning: Moderna Miracle? Autos Fly On Lockdown Easing, NY Governor...

May 18, 2020

Market Morning: London Legalizes Moving, Congress and Fed Want More Spending,...

May 13, 2020

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.